Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS‐ADONIS trials

BACKGROUND: The use of antiarrhythmic drugs (AADs) in patients with chronic kidney disease (CKD) is complex because impaired renal clearance can cause increased drug levels, and risk of intolerance or adverse events. Due to the propensity for CKD to occur alongside atrial fibrillation/atrial flutter...

Descripción completa

Detalles Bibliográficos
Autores principales: Thind, Munveer, Zareba, Wojciech, Atar, Dan, Crijns, Harry J. G. M., Zhu, Jun, Pak, Hui‐Nam, Reiffel, James, Ludwigs, Ulf, Wieloch, Mattias, Stewart, John, Kowey, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799050/
https://www.ncbi.nlm.nih.gov/pubmed/35019175
http://dx.doi.org/10.1002/clc.23765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799050/
https://www.ncbi.nlm.nih.gov/pubmed/35019175
http://dx.doi.org/10.1002/clc.23765

Ejemplares similares